The Indian government currently has no plans to ban Ranitidine, a stomach acid reducer, despite international concerns about impurities. Actions include testing and communication with drug ...
The FDA has been investigating NDMA and other nitrosamine impurities in blood pressure and heart failure medicines called angiotensin II receptor blockers or ‘sartans’ since last year ...
NDMA is classified as a probable human carcinogen ... Currently, there is no evidence that medicines containing this type of impurity have caused any harm to patients, say experts.
It follows concern in several countries over the presence of impurities in Zantac and other ... review the presence of N-nitrosodimethylamine (NDMA) in medicines containing the drug ranitidine.
The National Data Management Authority (NDMA) yesterday said that its cybersecurity team comprising Justino DaSilva, Shameer Jalim, Maryam Bacchus, Latoya Etkins, and Irshad Nasir achieved a ...